This article is more than 5 years old. Information may no longer be current.
Sildenafil shown to expand choroidal vessels in patients with AMD
Click Here to Manage Email Alerts
Researchers found that sildenafil citrate increases choroidal thickness in eyes with both wet and dry age-related macular degeneration.
Vuong and colleagues reported at the Association for Research in Vision and Ophthalmology meeting that they evaluated enhanced-depth optical coherence tomography images from 18 eyes of nine adults with neovascular AMD in one eye and non-neovascular AMD in the other, at 1 and 3 hours after oral administration of 100 mg sildenafil citrate.
Mean patient age was 76.2 years. Baseline choroidal thickness was 172.35 mm and 192.62 mm for eyes with non-neovascular and neovascular AMD, respectively.
Choroidal thickness increased by 10.1% in eyes with neovascular AMD at 1 hour and 11.5% at 3 hours after oral sildenafil. Choroidal thickness increased by 6.7% in eyes with non-neovascular AMD and 11.9% at 1 and 3 hours.
Researchers found no significant difference in choroidal thickness measurements between fellow eyes with non-neovascular vs. neovascular AMD after oral sildenafil at any time point.
Furthermore, eyes with reticular pseudodrusen and geographic atrophy showed less choroidal thickening at 3 hours, but number of prior anti-VEGF injections did not impact choroidal response to sildenafil.
OCT-angiography showed up to 37% and 31% increase in choroidal vascular diameter within both Haller’s and Sattler’s layer in eyes with neovascular and non-neovascular AMD, respectively.
The researchers determined that eyes with non-neovascular AMD demonstrate a slower rate of increase, particularly in the presence of reticular pseudodrusen and geographic atrophy, suggesting that reduced choroidal vascular compliance may play a role in the pathogenesis of some forms of AMD, according to a research summary provided to ARVO by the lead author.
Reference:
Vuong VS, et al. Effect of sildenafil citrate on choroidal thickness in age-related macular degeneration. Presented at: Association of Research in Vision and Ophthalmology annual meeting; May 7-11, 2017; Baltimore.
Disclosure: The researchers report no relevant financial disclosures.